Insights into Company

Rashi Peripherals Limited

πŸ“ Mumbai, Maharashtra, India Active NSE RPTECH CIN L30007MH1989PLC051039
Search companies

Key Metrics of Rashi Peripherals Limited

Revenueβ‚Ή15,173 Crβ–² 14.4% YoYFY 2025-26
EBITDAβ‚Ή475 Crβ–² 34.5% YoY
Net profitβ‚Ή261 Crβ–² 29.0% YoY
Net worthβ‚Ή1,986 Crβ–² 15.6% YoY

About Rashi Peripherals Limited

Company details

Registered office
Ariisto House, 5th Floor, Corner Of Telli Galli, Andheri East, Mumbai, In-mh, 400069
Listed
NSE: RPTECH Β· β‚Ή805.30

Company summary

Entity details

CINL30007MH1989PLC051039
LEI code33580098A6ZHLVHU5776
State codeMH
PIN code400069
Current legal nameRASHI PERIPHERALS LIMITED
Classificationβ€”
Listing statusListed (NSE: RPTECH)
Registration no.051039
Company ageβ€”
PANβ€”
CountryIndia
CityMumbai
StateMaharashtra
Current statusActive
Date of incorporationβ€”
Registrar of companiesβ€”
Authorised capitalβ€”
Paid-up capitalβ€”
Employee countβ€”

Compliance

Last AGM dateβ€”
Last balance sheetβ€”
Next filing dueAOC-4 for FY 2025-26 Β· 30 Oct 2026

Industry classification

NIC code30007
Description of main activityManufacture of office, accounting and computing machinery
Description of business activityManufacture of office, accounting and computing machinery
SectorOther Industries Β· Discovered Companies
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date Β· 1 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date Β· 31 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE Β· 07 Jan 2022 Withdrawn Positive outlook Β· Short term A2 Β· Withdrawn
Change in last 12 monthsNo change
Change since first rating on recordβ€”since Apr 2019
Rating actions50 up Β· 0 down

NoteLatest action: rating withdrawn (CARE, 07 Jan 2022)

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
07 Jan 2022CAREWithdrawn A-A2Positiveβ€” View
17 Jun 2021CAREOther β€”β€”β€”β€” View
09 Sep 2020CAREOther β€”β€”β€”β€” View
06 Apr 2020CAREOther β€”β€”β€”β€” View
05 Apr 2019CAREAssigned A-A2Stableβ‚Ή991 Cr View

Credit strengths (CARE, Jan 2022)

β€”

Credit challenges

βˆ’ Thin operating margins due to trading nature of business and highly competitive market conditions

Due to low value additive nature of the IT distribution business, the profitability of Rashi continues to remain thin. However, led by change in product mix coupled with higher early payment incentive, Rashi’s PBILDT margin improved to 3.36% during FY21, as compared to 2.39% in FY20. Working capital intensive business; albeit moderation was witnessed in utilisation of working capital facility due to improved collection efficiency

βˆ’ Moderate capital structure

Overall gearing ratio has stood stable Y-o-Y at 1.36x and total outside liabilities to net worth has improved to 3.12x (vs 3.36x as on March 31, 2020) as on March 31, 2021, on account of higher accretion to reserves. Moreover, the interest coverage ratio improved to 6.59x during FY21 (vs PY: 2.54x) on account of substantial increase in PBILDT and decreased interest expense Y-o- Y, owing to better collections and decrease interest rates. Further overall gearing stood at 1.01x in H1FY22.

Could lead to an upgrade

ο‚· Total debt to GCA of less than 2.50x on sustained basis ο‚· PBILDT/ Interest coverage more than 6 times on sustained basis

Could lead to a downgrade

ο‚· PBILDT margin falling below 1.50%. ο‚· ROCE falling below 14%. ο‚· Operating cycle more than 50 days

Agency-reported financials (CARE, 07 Jan 2022)

MetricH1FY22
Total operating incomeβ‚Ή4,373 Cr
PBILDTβ‚Ή166 Cr
PATβ‚Ή100 Cr
Overall gearing (times)1.01Γ—
Interest coverage (times)5.53Γ—
EBITDA margin3.8%
Implied interest cost (EBITDA Γ· coverage)β‚Ή30.02 Cr
PAT margin2.3%

Borrowings & rated debt

Rated borrowing limits (latest)β‚Ή991 Cr
Limits raised0 times2 new facilities rated

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Facilities Action Long-term Bank Facilities [ Single A MinusWorking capital & bank linesβ€”β‚Ή488 Crβ€” A- (Stable)AssignedCARE
] Short-term Bank FacilitiesWorking capital & bank linesβ€”β‚Ή8.00 Crβ€” A2AssignedCARE
[A Two] Total Facilities (Rupees Four hundred ninety five crore seventy lakh only) Details of facilities in Annexure-1Otherβ€”β‚Ή496 Crβ€” β€”OtherCARE

CARE ratings on record (checked 22 Oct 2026)

InstrumentAmountRating
Bank Guaranteeβ€”Withdrawn
Long Termβ€”Withdrawn

Credit assessment Β· Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) Β· Standalone accounts Β· FY 2025-26

Indicative long-termβ€”
Indicative short-termβ€”
Scoreβ€”
LiquidityStretched
DirectionStable
CARE rating Β· Jun 2021β€”

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
WithdrawalCARE Β· 07 Jan 2022 Β· Withdrawn (reason not stated in report)
Next action stable or better (model)35%
Information on file67% Β· missing: Capex / investment plans, Auditor details, Recent rating review (last 15 months)

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding difficult Next rating action stable or better: 41% (At risk of downgrade) Β· ML model on 4072 rating histories, AUC 0.666
Rated limitsβ€”
Not yet allocatedβ€”
Extra debt within 2.5Γ— EBITDAβ€”
Interest coverageβ€”
Limit utilisationβ€”
Open bank charges0 Β· β€”
  • Credit outlook model: 41% chance the next rating action is stable or better
  • CARE withdrew its ratings on 07 Jan 2022 β€” usually after the rated bank loans were repaid or moved to another lender

Rated limits by facility

Timeline

07 Jan 2022 CARE withdrawn: A- (Positive) CARE rationale
17 Jun 2021 CARE other: β€” CARE rationale
09 Sep 2020 CARE other: β€” CARE rationale
06 Apr 2020 CARE other: β€” CARE rationale
05 Apr 2019 CARE assigned: A- (Stable)Rated limits β‚Ή991.4 cr CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered officeARIISTO HOUSE, 5TH FLOOR, CORNER OF TELLI GALLI, ANDHERI EAST, MUMBAI, IN-MH, 400069
GSTINβ€”
Emailβ€”
Websiteβ€”
Members / shareholdersβ€”

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.